Mesa Laboratories Inc
NASDAQ:MLAB
| US |
|
Johnson & Johnson
NYSE:JNJ
|
Pharmaceuticals
|
| US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
Financial Services
|
| US |
|
Bank of America Corp
NYSE:BAC
|
Banking
|
| US |
|
Mastercard Inc
NYSE:MA
|
Technology
|
| US |
|
UnitedHealth Group Inc
NYSE:UNH
|
Health Care
|
| US |
|
Exxon Mobil Corp
NYSE:XOM
|
Energy
|
| US |
|
Pfizer Inc
NYSE:PFE
|
Pharmaceuticals
|
| US |
|
Palantir Technologies Inc
NYSE:PLTR
|
Technology
|
| US |
|
Nike Inc
NYSE:NKE
|
Textiles, Apparel & Luxury Goods
|
| US |
|
Visa Inc
NYSE:V
|
Technology
|
| CN |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
Retail
|
| US |
|
3M Co
NYSE:MMM
|
Industrial Conglomerates
|
| US |
|
JPMorgan Chase & Co
NYSE:JPM
|
Banking
|
| US |
|
Coca-Cola Co
NYSE:KO
|
Beverages
|
| US |
|
Walmart Inc
NYSE:WMT
|
Retail
|
| US |
|
Verizon Communications Inc
NYSE:VZ
|
Telecommunication
|
If you don’t study any companies, you have the same success buying stocks as you do in a poker game if you bet without looking at your cards.
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
Do you really want to delete this note?
This action cannot be undone.
| 52 Week Range |
84.94
140.86
|
| Price Target |
|
We'll email you a reminder when the closing price reaches USD.
Choose the stock you wish to monitor with a price alert.
|
|
Johnson & Johnson
NYSE:JNJ
|
US |
|
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
US |
|
|
Bank of America Corp
NYSE:BAC
|
US |
|
|
Mastercard Inc
NYSE:MA
|
US |
|
|
UnitedHealth Group Inc
NYSE:UNH
|
US |
|
|
Exxon Mobil Corp
NYSE:XOM
|
US |
|
|
Pfizer Inc
NYSE:PFE
|
US |
|
|
Palantir Technologies Inc
NYSE:PLTR
|
US |
|
|
Nike Inc
NYSE:NKE
|
US |
|
|
Visa Inc
NYSE:V
|
US |
|
|
Alibaba Group Holding Ltd
NYSE:BABA
|
CN |
|
|
3M Co
NYSE:MMM
|
US |
|
|
JPMorgan Chase & Co
NYSE:JPM
|
US |
|
|
Coca-Cola Co
NYSE:KO
|
US |
|
|
Walmart Inc
NYSE:WMT
|
US |
|
|
Verizon Communications Inc
NYSE:VZ
|
US |
This alert will be permanently deleted.
Mesa Laboratories Inc
Wall Street
Price Targets
MLAB Price Targets Summary
Mesa Laboratories Inc
According to Wall Street analysts, the average 1-year price target for
MLAB
is 136 USD
with a low forecast of 121.2 USD and a high forecast of 157.5 USD.
MLAB Last Price Targets
Mesa Laboratories Inc
The latest public price target was made on Aug 27, 2024 by
Brandon Couillard
from
Wells Fargo
,
who expects
MLAB
stock to
drop by 9%
over the next 12 months.
You can read more about this price target by viewing
the article on TheFly.
| Analyst | Price Target | Date | Article |
|---|---|---|---|
Brandon Couillard
Wells Fargo
|
120
USD
Downside 9% |
3 months ago
Aug 27, 2024
|
Mesa Labs initiated with an Underweight at Wells Fargo
TheFly
|
Vijay Kumar
Evercore ISI
|
120
USD
Downside 9% |
6 months ago
Jun 7, 2024
|
Evercore ISI Removes Mesa Laboratories (MLAB) from TAP List
StreetInsider
|
Price Targets
Operating Income
Forecast
Operating Income Estimate
Mesa Laboratories Inc
For the last 8 years the
compound annual growth rate for
Mesa Laboratories Inc's operating income is
-21%.
The projected
CAGR
for the next 3 years is
205%.
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.
What is MLAB's stock price target?
Price Target
136
USD
According to Wall Street analysts, the average 1-year price target for
MLAB
is 136 USD
with a low forecast of 121.2 USD and a high forecast of 157.5 USD.
What is Mesa Laboratories Inc's Revenue forecast?
Projected CAGR
7%
For the last 8 years the
compound annual growth rate for
Mesa Laboratories Inc's revenue is
12%.
The projected
CAGR
for the next 3 years is
7%.
What is Mesa Laboratories Inc's Operating Income forecast?
Projected CAGR
205%
For the last 8 years the
compound annual growth rate for
Mesa Laboratories Inc's operating income is
-21%.
The projected
CAGR
for the next 3 years is
205%.
You don't have any saved screeners yet
